ELEBRATO Trademark

Trademark Overview

On Wednesday, December 21, 2011, a trademark application was filed for ELEBRATO with the United States Patent and Trademark Office. The USPTO has given the ELEBRATO trademark a serial number of 85500726. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 6, 2019. This trademark is owned by Glaxo Group Limited. The ELEBRATO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, gene and cell therapy
elebrato

General Information

Serial Number85500726
Word MarkELEBRATO
Filing DateWednesday, December 21, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 6, 2019
Registration Number4284982
Registration DateTuesday, February 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2012

Trademark Statements

Goods and ServicesMedical services, namely, gene and cell therapy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 6, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, September 6, 2019CANCELLED SEC. 8 (6-YR)
Monday, February 5, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 5, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, November 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 18, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 18, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 18, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 18, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 5, 2012ASSIGNED TO LIE
Wednesday, September 26, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 20, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

elebrato cell therapy gene namely services medical